The cancer defense.

• Autores: Karen Weintraub
• Localización: Scientific American, ISSN 0036-8733, Vol. 314, Nº. 4, 2016, págs. 42-51
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The article focuses on immunotherapy treatment for aggressive skin and lung cancers which have caused apparent cancer remission. It comments on the monoclonal antibody rituximab which signals T cells to attack the B cell protein CD20 found on normal and cancerous B cells and the development of an alternative drug that targets the B cell protein CD19 but can also cause cytokine release syndrome. It talks about research of the immunotherapy ipilimumab for treating solid tumors in melanoma.